Brief: Mateon announces issuance of US patent for Cathepsin
10/10/2016 13:32
Oct 10 (Reuters) - Mateon Therapeutics Inc MATN.O :
* Mateon announces issuance of US patent for Cathepsin
inhibition
Source text for Eikon: urn:newsml:reuters.com:*:nGNXNHITGa
Further company coverage: MATN.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas